Anavex Life Sciences Corp (AVXL)

[JB3729]

While the patent apps play out -

Keep in mind the 5 years of market exclusivity that would be granted to Anavex if FDA approval is obtained from the current trial path.

In 5 years Anavex can test combos of A2-73 and other drugs and develop A3-71.

I'm encouraged by the latest reply by the patent examiner regarding A2-73 and donepezil. While the examiner is looking for more proof of synergy for A2-73/donepezil, he did concede that they are synergistic.